Merck KGaA, Pharmstandard deal

Pharmstandard will produce Rebif interferon beta-1a for multiple sclerosis (MS) from Merck’s Merck Serono S.A. unit at its Pharmstandard-UfaVITA plant in Ufa, Russia. Pharmstandard also will provid...